G1 Therapeutics Inc (NAS:GTHX)
$ 7.15 0 (0%) Market Cap: 377.22 Mil Enterprise Value: 364.45 Mil PE Ratio: 0 PB Ratio: 15.31 GF Score: 31/100

G1 Therapeutics Inc Corporate Analyst Meeting Transcript

Mar 06, 2019 / 01:00PM GMT
Release Date Price: $17.31 (-16.42%)
Jeff Macdonald
G1 Therapeutics, Inc. - Head of Investor & Public Relations

Good morning, everyone. I think we're going to get started. First off, I wanted to thank everyone who's joined us here in New York as well as those of you on the webcast to G1 Therapeutics' First Investor Day.

Before we begin the program, I just would like to remind everyone that today's presentation will have forward-looking statements. You can see our full forward-looking statement here. You can also reference our filings with the SEC on our corporate website. So we encourage you to take a look at those.

Just a couple of housekeeping notes. There'll be Q&A sessions both in between -- in between both the trilaciclib and lerociclib/G1T48 sections of the agenda. For those of you in the room, if you're going to ask questions, there'll be someone with a microphone. Please ask your questions into the microphone and identify yourself, so the folks on the webcast can hear you. For those of you joining us by webcast, you can submit questions via the "Ask a Question" link that's at the top right of your screen.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot